Genetic and cellular techniques emerge as promising modalities for the treatment of diabetic foot syndrome
Two patient groups potentially to benefit most from these novel methods are patients with critical lower limb ischemia (CLLI) in whom angiosurgery is not indicated, and patients with trophic ulcers resistant to conventional therapy. A series of clinical trials has shown positive effects of transferr...
Main Authors: | Vladimir Iosifovich Konenkov, Vadim Valerievich Klimontov |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2014-03-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/6340/4318 |
Similar Items
-
Foot Revascularization Avoids Major Amputation in Persons with Diabetes and Ischaemic Foot Ulcers
by: Marco Meloni, et al.
Published: (2021-09-01) -
Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research
by: Lara Lopes, et al.
Published: (2018-07-01) -
Wound bandage basing on lipidocolloid technology application experience in outpatient treatment of foot trophic ulcer
by: V B Bregovskyi
Published: (2011-03-01) -
Editorial: Understanding Diabetic Foot Disease: Current Status and Emerging Treatment Approaches
by: Nikolaos Tentolouris, et al.
Published: (2021-09-01) -
Vasculogenesis and angiogenesis in diabetes mellitus: novel pathogenetic concepts for treatment of vascular complications
by: Vladimir Iosifovich Konenkov, et al.
Published: (2012-12-01)